Last reviewed · How we verify
fluid administration
At a glance
| Generic name | fluid administration |
|---|---|
| Also known as | Haes Steril, Fresenius Kabi |
| Sponsor | Fondazione Poliambulanza Istituto Ospedaliero |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Individualized Precision Isavuconazole Therapy Guided by PK/PD Principles for the Geriatric Population
- Alesis OSA-1 Obstructive Sleep Apnea Treatment (NA)
- Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1) (PHASE1)
- pAF for the Treatment of Osteoarthritis (PHASE1, PHASE2)
- Can Imaging be an Alternative to Exercise Testing as a Predictor of Surgical Fitness?
- Sphenopalatine Ganglion Block for Post-Dural Puncture Headache: A Pilot Randomised Controlled Trial (NA)
- Individualized Precision Therapy With Ceftazidime and Avibactam Guided by PK/PD in Geriatric Populations
- Acupuncture for Colorectal sUrgery Recovery Enhancement: A Randomized Controlled Trial Evaluating Gastrointestinal Functional Recovery After Minimally Invasive Resection (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- fluid administration CI brief — competitive landscape report
- fluid administration updates RSS · CI watch RSS
- Fondazione Poliambulanza Istituto Ospedaliero portfolio CI